Taro Net Interest Income vs Total Other Income Expense Net Analysis

TARO Stock  USD 42.73  0.01  0.02%   
Taro Pharmaceutical financial indicator trend analysis is much more than just breaking down Taro Pharmaceutical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Taro Pharmaceutical is a good investment. Please check the relationship between Taro Pharmaceutical Net Interest Income and its Total Other Income Expense Net accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Net Interest Income vs Total Other Income Expense Net

Net Interest Income vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Taro Pharmaceutical Net Interest Income account and Total Other Income Expense Net. At this time, the significance of the direction appears to have no relationship.
The correlation between Taro Pharmaceutical's Net Interest Income and Total Other Income Expense Net is 0.0. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of Taro Pharmaceutical Industries, assuming nothing else is changed. The correlation between historical values of Taro Pharmaceutical's Net Interest Income and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Taro Pharmaceutical Industries are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Net Interest Income i.e., Taro Pharmaceutical's Net Interest Income and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

0.0
Relationship DirectionFlat 
Relationship StrengthInsignificant

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Total Other Income Expense Net

Most indicators from Taro Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Taro Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
As of the 17th of June 2024, Selling General Administrative is likely to drop to about 83.4 M. In addition to that, Discontinued Operations is likely to drop to about (404.5 K)
 2021 2022 2023 2024 (projected)
Gross Profit293.1M268.3M305.0M238.5M
Total Revenue561.3M573.0M629.2M365.8M

Taro Pharmaceutical fundamental ratios Correlations

-0.60.620.610.980.81-0.760.950.680.750.030.910.520.45-0.050.81-0.720.540.910.120.44-0.130.00.38-0.410.49
-0.6-0.48-0.27-0.62-0.180.44-0.71-0.35-0.490.12-0.59-0.160.330.49-0.350.73-0.19-0.520.02-0.280.370.07-0.240.34-0.31
0.62-0.480.850.490.48-0.260.660.180.90.140.32-0.17-0.050.390.73-0.820.780.29-0.380.57-0.57-0.530.51-0.440.62
0.61-0.270.850.450.57-0.310.530.260.740.250.340.150.30.540.75-0.550.960.39-0.250.46-0.08-0.130.42-0.330.52
0.98-0.620.490.450.77-0.790.950.710.67-0.020.950.540.42-0.20.73-0.680.370.940.20.39-0.130.030.33-0.390.43
0.81-0.180.480.570.77-0.610.710.640.650.040.690.480.740.260.74-0.530.630.720.040.31-0.05-0.070.24-0.090.37
-0.760.44-0.26-0.31-0.79-0.61-0.65-0.97-0.310.38-0.88-0.66-0.420.19-0.30.33-0.3-0.86-0.390.14-0.09-0.250.160.130.1
0.95-0.710.660.530.950.71-0.650.540.830.120.830.290.23-0.180.82-0.860.420.80.00.58-0.35-0.190.53-0.570.63
0.68-0.350.180.260.710.64-0.970.540.21-0.470.830.710.49-0.120.21-0.240.310.810.42-0.270.140.27-0.30.07-0.23
0.75-0.490.90.740.670.65-0.310.830.210.270.44-0.110.110.220.87-0.90.640.41-0.370.71-0.57-0.520.65-0.570.76
0.030.120.140.25-0.020.040.380.12-0.470.27-0.18-0.250.17-0.020.46-0.090.11-0.12-0.340.730.09-0.010.82-0.60.68
0.91-0.590.320.340.950.69-0.880.830.830.44-0.180.690.45-0.280.54-0.50.30.980.350.140.040.220.1-0.230.18
0.52-0.16-0.170.150.540.48-0.660.290.71-0.11-0.250.690.64-0.080.190.110.220.780.62-0.230.670.71-0.260.23-0.2
0.450.33-0.050.30.420.74-0.420.230.490.110.170.450.640.270.430.130.370.540.290.070.530.420.060.060.08
-0.050.490.390.54-0.20.260.19-0.18-0.120.22-0.02-0.28-0.080.270.250.020.64-0.21-0.240.040.0-0.28-0.020.260.1
0.81-0.350.730.750.730.74-0.30.820.210.870.460.540.190.430.25-0.720.650.58-0.130.81-0.19-0.20.75-0.560.85
-0.720.73-0.82-0.55-0.68-0.530.33-0.86-0.24-0.9-0.09-0.50.110.130.02-0.72-0.47-0.440.32-0.590.690.58-0.520.46-0.65
0.54-0.190.780.960.370.63-0.30.420.310.640.110.30.220.370.640.65-0.470.35-0.210.3-0.04-0.110.25-0.070.36
0.91-0.520.290.390.940.72-0.860.80.810.41-0.120.980.780.54-0.210.58-0.440.350.40.170.170.320.12-0.220.2
0.120.02-0.38-0.250.20.04-0.390.00.42-0.37-0.340.350.620.29-0.24-0.130.32-0.210.4-0.260.510.61-0.290.18-0.31
0.44-0.280.570.460.390.310.140.58-0.270.710.730.14-0.230.070.040.81-0.590.30.17-0.26-0.32-0.290.99-0.790.99
-0.130.37-0.57-0.08-0.13-0.05-0.09-0.350.14-0.570.090.040.670.530.0-0.190.69-0.040.170.51-0.320.91-0.270.25-0.34
0.00.07-0.53-0.130.03-0.07-0.25-0.190.27-0.52-0.010.220.710.42-0.28-0.20.58-0.110.320.61-0.290.91-0.250.13-0.32
0.38-0.240.510.420.330.240.160.53-0.30.650.820.1-0.260.06-0.020.75-0.520.250.12-0.290.99-0.27-0.25-0.830.96
-0.410.34-0.44-0.33-0.39-0.090.13-0.570.07-0.57-0.6-0.230.230.060.26-0.560.46-0.07-0.220.18-0.790.250.13-0.83-0.77
0.49-0.310.620.520.430.370.10.63-0.230.760.680.18-0.20.080.10.85-0.650.360.2-0.310.99-0.34-0.320.96-0.77
Click cells to compare fundamentals

Taro Pharmaceutical Account Relationship Matchups

Taro Pharmaceutical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.3B2.4B2.2B2.1B2.2B2.3B
Other Current Liab192.1M605.9M355.9M314.2M316.4M332.3M
Total Current Liabilities222.7M676.3M432.1M385.5M361.1M379.2M
Total Stockholder Equity2.1B1.7B1.7B1.7B1.8B1.9B
Property Plant And Equipment Net210.0M205.5M199.7M190.1M217.6M124.8M
Net Debt(511.8M)(603.5M)(248.9M)(152.5M)(362.9M)(344.8M)
Retained Earnings2.7B2.3B2.4B2.4B2.8B2.9B
Cash513.4M605.2M251.1M154.5M362.9M186.1M
Non Current Assets Total808.7M936.0M838.5M799.1M858.7M901.6M
Non Currrent Assets Other3.5M4.3M6.8M83.1M82.5M86.6M
Cash And Short Term Investments1.1B1.0B820.7M850.3M879.4M923.3M
Net Receivables270.8M266.9M306.7M259.5M177.5M150.9M
Common Stock Shares Outstanding38.5M38.2M37.6M37.6M43.2M32.5M
Liabilities And Stockholders Equity2.3B2.4B2.2B2.1B2.2B2.3B
Non Current Liabilities Total8.8M35.1M32.8M19.1M8.0M7.6M
Inventory153.1M180.3M210.4M226.7M204.8M215.1M
Other Stockholder Equity(459.1M)(484.0M)(509.0M)(509.0M)(458.1M)(435.2M)
Total Liab231.5M711.4M464.9M404.7M369.1M219.5M
Total Current Assets1.5B1.5B1.3B1.3B1.3B1.4B
Short Term Debt1.5M1.7M2.2M2.0M2.2M2.1M
Intangible Assets21.7M19.8M60.1M76.1M87.6M91.9M
Accounts Payable28.9M61.2M68.2M68.5M44.7M73.5M
Other Current Assets8.8M12.9M14.2M(1K)41.8M35.7M
Property Plant And Equipment Gross212.2M205.5M516.1M525.6M604.4M634.6M
Accumulated Other Comprehensive Income(163.0M)(151.6M)(169.0M)(175.0M)(157.5M)(149.6M)
Other Liab7.4M7.6M33.8M28.8M33.2M34.8M
Current Deferred Revenue237K7.6M5.8M903K812.7K772.1K
Other Assets121.3M156.6M139.0M1.01.151.09
Short Term Investments595.4M418.5M569.6M695.8M516.4M324.5M
Property Plant Equipment190.7M193.9M187.6M181.4M208.6M186.0M
Net Tangible Assets1.9B2.1B1.7B1.6B1.9B1.9B
Long Term Investments459.6M557.2M435.2M404.9M465.6M292.1M
Non Current Liabilities Other2.7M1.6M4.1M2.7M3.1M2.0M
Net Invested Capital2.1B1.7B1.7B1.7B1.6B1.5B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Taro Stock

When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.181
Earnings Share
1.43
Revenue Per Share
16.74
Quarterly Revenue Growth
0.125
Return On Assets
0.0021
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.